Aziyo Biologics Inc - Class A
AZYO
Get informed when a big investor buys or sells
+ FollowMarket Cap$24.21M
Close$
Share Statistics
| Market cap | $24.21 Million |
|---|---|
| Enterprise Value | $1.82 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.29 |
| Beta | -0.08 |
| Outstanding Shares | 42,998,504 |
Return
| Return on Equity | 221.26% |
|---|---|
| Return on Assets | 90.28% |
| Return on Invested Capital | -89.85% |
Valuation & Multiples
| P/E Ratio | 1 |
|---|---|
| PEG | 1.11 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.65 |
| Enterprise Value to EBIT | -0.06 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 3.35 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 36.78%▼ 2.50% |
|---|---|
| Total Invested | $16.00M▲ 43.49% |
| Investors Holding | 34▲ 1.00% |
ESG Score
No data
About Aziyo Biologics Inc
163 employeesAziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable...